Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Six weeks of fund outflows from US spot BTC ETFs weigh on Bitcoin as the price drops to 21-month lows. Long-term hold...
Investors are weighing big potential against real-world risk. This article breaks down VK2735, market dynamics, and w...
Bitcoin closed June at a two-year low as ETF outflows accelerated and institutional interest remained restrained. The...
As of July 8, 2026, investors are weighing how a $300,000 portfolio can yield steady monthly income. Three clear path...
The first half of 2026 handed investors a harsh lesson on how fast sentiment can turn in ad tech. This article breaks...
A batch of midweek analyst notes lifts several big names, steering markets higher as investors weigh price targets, e...
Founders Fund's ETHZilla fully liquidates its ether holdings, selling $74.5 million as the crypto market slides. The ...
A Supreme Court ruling nullifies broad tariffs, but a mid-sized U.S. coffee roaster warns refunds are unlikely and co...
Bitcoin edges toward a pivotal support zone as options activity and on-chain data point to renewed downside risk. Coi...
Solventum wraps up 2025 with meaningful growth and a clearer path to profitability. This article breaks down the numb...
January 2026 saw natural gas price spikes then a rapid collapse, with the UNG ETF tracking every twist. Traders say t...